The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.
The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.
The Department of Health and Human Services (HHS) issued a statement on Sunday:
The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.
Canadian PM Carney says he was prepared for Trump ordering invasion
Soros-linked prosecutor faces primary challenge as fellow Democrat targets his record
Todd Blanche vows Supreme Court appeal after court blocks third-country deportations
Reform slips behind Labour and Conservatives in latest voter poll thanks to ‘Burnham bounce’
Xi announces new pandas coming to Atlanta in coming days
‘So Look…’: El-Sayed Answers Whether a ‘Jewish Zionist’ Has a Place in the New Democratic Party
Bombshell: CNN’s Entire Newsroom May End up Working for Elon Musk as Paramount-WB Merger Steamrolls Lefties
Biden-appointed judge hands Letitia James setback in latest Trump legal clash
Florida deputies taser sword-wielding burglary suspect, video shows
Top public university’s ‘LGBTQ+ lab’ hit with race-bias complaint amid $700K in Trump-era federal funding
Texas triple murderer uses last words before execution to send message to death row inmates
Ken Paxton Shuts Down Alleged Chinese ‘Birth Tourism Center’ Ahead of Race Against Talarico
Trump-Xi summit could hold key to lower gas prices, GOP chairman says
Italy Scrambles Warships Toward Red Sea as Houthis Close in on Global Shipping Chokepoint
Federal appeals court deals blow to Trump deportation agenda
HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”
Earlier, the French government had approved similar drugs to treat the virus.
Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”
Canadian PM Carney says he was prepared for Trump ordering invasion
Soros-linked prosecutor faces primary challenge as fellow Democrat targets his record
Todd Blanche vows Supreme Court appeal after court blocks third-country deportations
Reform slips behind Labour and Conservatives in latest voter poll thanks to ‘Burnham bounce’
Xi announces new pandas coming to Atlanta in coming days
‘So Look…’: El-Sayed Answers Whether a ‘Jewish Zionist’ Has a Place in the New Democratic Party
Bombshell: CNN’s Entire Newsroom May End up Working for Elon Musk as Paramount-WB Merger Steamrolls Lefties
Biden-appointed judge hands Letitia James setback in latest Trump legal clash
Florida deputies taser sword-wielding burglary suspect, video shows
Top public university’s ‘LGBTQ+ lab’ hit with race-bias complaint amid $700K in Trump-era federal funding
Texas triple murderer uses last words before execution to send message to death row inmates
Ken Paxton Shuts Down Alleged Chinese ‘Birth Tourism Center’ Ahead of Race Against Talarico
Trump-Xi summit could hold key to lower gas prices, GOP chairman says
Italy Scrambles Warships Toward Red Sea as Houthis Close in on Global Shipping Chokepoint
Federal appeals court deals blow to Trump deportation agenda
President Donald Trump has suggested that hydroxychloroquine could be effective, and has encouraged further study. His interest in the drug has prompted pushback from the media.
NBC News’ Peter Alexander accused the president last week of giving Americans “false hope,” and Politico’s Dan Diamond reported Sunday that the FDA decision came despite “scant evidence,” adding that “[c]areer scientists have been skeptical of the effort.”
Story cited here.
